Disruptive Delivery Company Signs Deal for Cannabis Distribution
Source: Clive Maund for Streetwise Reports  (3/15/19)
Technical analyst Clive Maund discusses both the fundamentals and technicals for this company that just signed a cannabis distribution agreement with a Vancouver-based retailer. More >

Logistics Firm Moves Further Toward Becoming 'Uber of Cannabis for Canada'
Source: Streetwise Reports  (3/14/19)
This company forges partnerships with cannabis companies to deliver, within an hour, their products to customers. More >

Tech Firm Launches Augmented Reality Showcase for Legal Cannabis Products
Source: Streetwise Reports  (3/14/19)
The new platform promises to provide a unique e-commerce experience in the legal cannabis industry, combining customer education and support for online transactions. More >

Marijuana: Up in Smoke
Source: Ron Struthers for Streetwise Reports  (3/13/19)
Sector expert Ron Struthers takes a look at a spectrum of cannabis companies, including one company that's gone from a high to a downer, a sector leader, and a firm that promotes CBDs as good for sex. More >

Analyst: Biotech to Have 'Eventful Year' with Data Readouts in Three Indications
Source: Streetwise Reports  (3/12/19)
This California company expects results from clinical trials in liver disease and psoriasis in 2019. More >

Large US Market Now Open to Livestock Feed Antibiotic Replacement
Source: Streetwise Reports  (3/11/19)
Proprietary OxC-beta livestock feed supplement can supplant the need for maintenance antibiotics. More >

Coverage Initiated on Cancer Vaccine Firm
Source: Streetwise Reports  (3/9/19)
An H.C. Wainwright & Co. report explained the reasons for its "bullish view" on this California-based life sciences company. More >

Coverage Initiated on Producer of Hemp-Derived Cannabidiol Products
Source: Streetwise Reports  (3/9/19)
A ROTH Capital Partners report presented the reasons for investing in this company. More >

Augmented Reality and Healthcare Tech Firms to Collaborate
Source: Streetwise Reports  (3/8/19)
The companies aim to combine their expertise to co-create immersive and compelling instructive medical tools. More >

U.S. Biotech Makes 'The Acquisition We Were Waiting For'
Source: Streetwise Reports  (3/6/19)
By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. More >

Firm Launches App to Help Physicians Provide Virtual Counseling
Source: Streetwise Reports  (3/5/19)
This new initiative combines emerging technologies and human skill-based expertise. More >

After Financing Close, Biotech's Subsidiary to Operate Independently
Source: Streetwise Reports  (3/5/19)
An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. More >

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types
Source: Streetwise Reports  (2/27/19)
This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. More >

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease
Source: Streetwise Reports  (2/25/19)
The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. More >

Livestock Feed Developer Partners to Initiate Product Sales in the U.S.
Source: Streetwise Reports  (2/22/19)
The arrangement represents this Canadian life sciences firm's entrée into a significant market. More >

Biopharma's Foundation Provides for Downside Protection, Upside Realization
Source: Streetwise Reports  (2/20/19)
An H.C. Wainwright & Co. report described this Israeli firm's solid revenue picture and addressed the undervaluation of a key therapeutic candidate. More >

Canadian Company Completes Two Cannabis Harvests
Source: Streetwise Reports  (2/17/19)
The firm also makes progress in obtaining technology rights and various licenses. More >

Bringing Advanced Technology to the Cannabis Space
Source: Streetwise Reports  (2/13/19)
This cannabis technology company brings artificial intelligence, blockchain and cryptocurrency to the global medical cannabis marketplace to help patients make informed decisions and drive medical cannabis sales. More >

Biotech Identifies Antibody Drug Candidates to Target Toxic Protein Implicated in Parkinson's Disease
Source: Streetwise Reports  (2/13/19)
The Canadian company continues seeking partners to leverage its discovery and development platform. More >

Clinical Movement Expected in 2019 on Pharma Firm's 'Gene Therapy Promise'
Source: Streetwise Reports  (2/13/19)
A number of data readouts are expected in the coming months, which could derisk and accelerate development programs, according to an H.C. Wainwright & Co. report. More >

Report Highlights Biopharma's Breakthroughs on Treatment of Life-Threatening Pediatric Liver Diseases
Source: Streetwise Reports  (2/13/19)
Analyst expects "transformational year" for company with a phase 3 trial underway. More >

Biopharma's Drug Well Tolerated in Opioid Withdrawal Study
Source: Streetwise Reports  (2/9/19)
An H.C. Wainwright & Co. discussed these proof-of-concept data and described the company's planned Phase 1 study. More >

Medical Device Firm Develops Nitric Oxide Delivery Unit for Clinic Use
Source: Streetwise Reports  (2/6/19)
This new machine takes the company's product line count to four. More >

Is Elixinol the Fastest Growing Hemp/CBD Producer?
Source: Fincom Investment Partners for Streetwise Reports  (2/4/19)
Fincom Investment Partners discusses Elixinol's Q4 earnings, previews Charlotte's Web and CV Sciences' earnings, and compares the three companies. More >

Accelerated Approval Could Be 'Game Changer' for Biotech
Source: Streetwise Reports  (2/2/19)
This Canadian company's immunotherapeutic targeting ovarian cancer could advance to market sooner, according to a Mackie Research Capital Corp. note. More >